Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

Cannabidiolic Acid as a Selective Cyclooxygenase-2 Inhibitory Component in Cannabis

Shuso Takeda, Koichiro Misawa, Ikuo Yamamoto and Kazuhito Watanabe
Drug Metabolism and Disposition September 2008, 36 (9) 1917-1921; DOI: https://doi.org/10.1124/dmd.108.020909
Shuso Takeda
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Koichiro Misawa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ikuo Yamamoto
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kazuhito Watanabe
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 36 no. 9 1917-1921
DOI 
https://doi.org/10.1124/dmd.108.020909
PubMed 
18556441

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received February 7, 2008
  • Accepted June 10, 2008
  • Published online August 20, 2008.

Article Versions

  • Earlier version (June 12, 2008 - 10:04).
  • You are viewing the most recent version of this article.
Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Shuso Takeda,
  2. Koichiro Misawa,
  3. Ikuo Yamamoto and
  4. Kazuhito Watanabe
  1. Organization for Frontier Research in Preventive Pharmaceutical Sciences (S.T., K.W.) and Department of Hygienic Chemistry, Faculty of Pharmaceutical Sciences (K.M., K.W.), Hokuriku University, Kanazawa, Japan; and School of Pharmaceutical Sciences, Kyushu University of Health and Welfare, Nobeoka, Japan (I.Y.)
  1. Address correspondence to:
    Kazuhito Watanabe, Department of Hygienic Chemistry, Faculty of Pharmaceutical Sciences, Hokuriku University, Ho-3 Kanagawa-machi, Kanazawa 920-1181, Japan. E-mail: k-watanabe{at}hokuriku-u.ac.jp
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: June 2008 to February 2021

AbstractFullPdf
Jun 200845070
Jul 200837042
Aug 2008661234
Sep 2008821423
Oct 2008561524
Nov 20082477
Dec 20083186
Jan 20091647
Feb 20093075
Mar 200938715
Apr 2009461222
May 200915013
Jun 20092429
Jul 20092159
Aug 20091529
Sep 2009123125
Oct 2009161724
Nov 200923619
Dec 200929513
Jan 2010192131
Feb 201023426
Mar 201012636
Apr 2010242013
May 201017147
Jun 201030148
Jul 20101466
Aug 201011178
Sep 201027117
Oct 2010221913
Nov 20106378
Dec 201027459
Jan 2011113414
Feb 2011123213
Mar 201118515
Apr 201115356
May 2011113215
Jun 20118220
Jul 201133168
Aug 2011382210
Sep 201128369
Oct 201129407
Nov 2011232814
Dec 201123156
Jan 2012481617
Feb 2012242916
Mar 2012532822
Apr 2012223210
May 201229457
Jun 2012333717
Jul 2012294513
Aug 2012253625
Sep 2012214017
Oct 2012243220
Nov 2012376525
Dec 2012305712
Jan 2013397115
Feb 2013316827
Mar 2013405224
Apr 2013386014
May 2013346621
Jun 201324253
Jul 2013173210
Aug 201311479
Sep 2013164617
Oct 2013174411
Nov 2013306724
Dec 2013177316
Jan 201416538
Feb 2014176215
Mar 201425599
Apr 2014254710
May 201436284
Jun 20142415124
Jul 2014688137
Aug 2014307311
Sep 20141931815
Oct 2014427814
Nov 2014425821
Dec 201422838
Jan 201530739
Feb 201524455
Mar 20153813112
Apr 201533355
May 2015384911
Jun 2015265110
Jul 2015319116
Aug 2015296810
Sep 2015322839
Oct 201540749
Nov 2015394115
Dec 2015517222
Jan 2016395520
Feb 2016254718
Mar 2016323434
Apr 2016215218
May 201613576
Jun 2016154815
Jul 2016244612
Aug 2016313412
Sep 2016195226
Oct 201665013
Nov 2016154320
Dec 2016189310
Jan 20172710914
Feb 201771008
Mar 2017612111
Apr 201798511
May 20171816325
Jun 2017108913
Jul 20171310412
Aug 20172012317
Sep 20172711634
Oct 20172212623
Nov 20172110726
Dec 20172310020
Jan 20181813222
Feb 20182914939
Mar 20181927128
Apr 20181716827
May 20181717947
Jun 201847121142
Jul 2018916035
Aug 20181013629
Sep 20186416535
Oct 20184927053
Nov 20182526560
Dec 20182786138
Jan 2019375627
Feb 2019570315
Mar 2019407619
Apr 2019323417
May 20193711720
Jun 2019418711
Jul 2019332326
Aug 2019353412
Sep 2019413723
Oct 20193961427
Nov 2019358619
Dec 2019369413
Jan 2020433414
Feb 202028446
Mar 202031449
Apr 20202791015
May 202036568
Jun 2020466410
Jul 202031437
Aug 202043664
Sep 2020529149
Oct 202032646
Nov 2020364310
Dec 20204181012
Jan 2021525514
Feb 2021452315

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 36 (9)
Drug Metabolism and Disposition
Vol. 36, Issue 9
1 Sep 2008
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Cannabidiolic Acid as a Selective Cyclooxygenase-2 Inhibitory Component in Cannabis
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Cannabidiolic Acid as a Selective Cyclooxygenase-2 Inhibitory Component in Cannabis

Shuso Takeda, Koichiro Misawa, Ikuo Yamamoto and Kazuhito Watanabe
Drug Metabolism and Disposition September 1, 2008, 36 (9) 1917-1921; DOI: https://doi.org/10.1124/dmd.108.020909

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleArticle

Cannabidiolic Acid as a Selective Cyclooxygenase-2 Inhibitory Component in Cannabis

Shuso Takeda, Koichiro Misawa, Ikuo Yamamoto and Kazuhito Watanabe
Drug Metabolism and Disposition September 1, 2008, 36 (9) 1917-1921; DOI: https://doi.org/10.1124/dmd.108.020909
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • In Vivo Functional Effects of CYP2C9 M1L
  • Clearance pathways: fevipiprant with probenecid perpetrator
  • Predicting Volume of Distribution from In Vitro Parameters
Show more Articles

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics